TNF inhibitors effective in AS, PsA over 3-year period

06:30 EDT 3 Apr 2018 | Healio

Praveena Chiowchanwisawakit
Anti–TNF therapy is effective in patients with ankylosing spondylitis and psoriatic arthritis at 4 months, and becomes progressively more effective during the next 3 years, with a drug retention rate of approximately 60%, according to findings published in the Journal of Clinical Rheumatology.
“This study is one of a few Asian registries of patients with [spondyloarthritis] who were treated with TNF inhibitors after inadequate response or intolerance to [conventional synthetic disease-modifying antirheumatic drugs],” Praveena Chiowchanwisawakit, MD,

Original Article: TNF inhibitors effective in AS, PsA over 3-year period


More From BioPortfolio on "TNF inhibitors effective in AS, PsA over 3-year period"

Quick Search


Relevant Topics

Cytokine Tumour Necrosis Factor (TNF)
TNF is a compound that is classified as a cytokine which plays a central role in the cellular mechanisms of apoptosis or cell death. However, there are a number of different kinds of TNF, just under twenty, but the family of molecules have very similar a...

Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Joint Disorders
A joint is where two or more bones come together, like the knee, hip, elbow, or shoulder. Joints can be damaged by many types of injuries or diseases, including Arthritis - inflammation of a joint causes pain, stiffness, and swelling with ...